Zuellig Pharma has paid an undisclosed amount for portfolio company Klinify after investing in the healthcare data software provider two years ago.

The WuXi Biologics, Eli Lilly and Alexandria Real Estate Equities-backed cancer therapy developer is targeting $74.7m in its IPO.

Having confidentially filed in late April, Karuna Therapeutics has publicly applied for an initial public offering that would raise $75m and provide exits to Nan Fung and PureTech Health.

Rocket Internet, Access Industries and Tengelmann-backed fashion e-commerce marketplace GFG could float in Germany next month.

The second-hand luxury goods marketplace has set down a $100m target for an initial public offering that would offer an exit for Novel TMT Ventures.

National Electric Vehicle Sweden has acquired the in-wheel electric motor producer, enabling Zhejiang VIE Science & Technology and Tianjin THSG Corporation to exit.

The immunotherapy technology developer has set a $230m target for an initial public offering that would offer exits to LabCorp, Illumina, Celgene and BD Biosciences.

Novo, GlaxoSmithKline, Pfizer, AbbVie, ShangPharma and Schrödinger are all in line for exits following the small-molecule drug developer's decision to file for an $86.3m initial public offering.

Raksul has exited custom printed product marketplace InkMonk in an acquisition of undisclosed size by Printo, with the deal reportedly creating India's largest printing services provider.

Corporate venturing units GV, REV and MassMutual Ventures look set to exit the threat intelligence provider in a deal that values it at $780m.